Engineered CasX repressor systems

GB2625500BActive Publication Date: 2026-03-27SCRIBE THERAPEUTICS INC
View PDF 5 Cites 0 Cited by

Patent Information

Authority / Receiving Office
GB · GB
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-09-21
Publication Date
2026-03-27
Patent Text Reader

Abstract

The disclosure relates to gene repressor systems comprising catalytically-dead Class 2 CRISPR proteins and one or more transcription repressor domains linked to the catalytically-dead Class 2 CRISPR p
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    WO2013176772A1

  • RNA-guided nucleic acid modifying enzymes and methods of use thereof

    WO2018064371A1

  • CAS9-based transcription modulation systems

    WO2019079462A1

  • Engineered CASX systems

    WO2020247882A1

  • Particle delivery systems

    WO2021113772A1